Human kallikrein overexpression alleviates cardiac aging by alternatively regulating macrophage polarization in aged

Danli Hu1,2, Ruolan Dong3, Yan Yang1

  • 1Department of Geriatric Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Insights

Human kallikrein (hKLK1) overexpression alleviates cardiac aging by reducing fibrosis and improving heart function. It achieves this by regulating macrophage polarization and decreasing profibrotic signaling pathways.

Area of Science:

  • Cardiology
  • Aging Research
  • Molecular Biology

Background:

  • Cardiac aging involves hypertrophy, fibrosis, and diastolic dysfunction.
  • Human kallikrein (hKLK1) shows antifibrotic properties in various conditions.
  • The role of hKLK1 in cardiac aging and macrophage function is unexplored.

Purpose of the Study:

  • To investigate the effects of hKLK1 overexpression on cardiac aging.
  • To elucidate the mechanisms by which hKLK1 regulates aging-related cardiac fibrosis.
  • To explore hKLK1's impact on macrophage polarization in aging hearts.

Main Methods:

  • Echocardiography in aging rats with hKLK1 overexpression.
  • Analysis of cardiac gene/protein expression (MCP-1, TGF-β1-Smad3, JAK-STAT3 pathways).
  • In vitro studies on macrophage differentiation and migration (RAW264.7 cells, H2O2, IL-4, bradykinin).

Main Results:

  • hKLK1 overexpression protected against aging-induced cardiac dysfunction, hypertrophy, and fibrosis.
  • hKLK1 reduced monocyte chemoattractant protein 1, suppressed mitochondrial dysfunction, and decreased oxidative stress.
  • hKLK1 suppressed M2 macrophage recruitment and profibrotic cytokine secretion via TGF-β1-Smad3 and JAK-STAT3 pathways.

Conclusions:

  • hKLK1 overexpression alleviates cardiac aging and dysfunction in rats.
  • hKLK1 mitigates cardiac fibrosis by reducing M2 macrophage polarization and related signaling.
  • hKLK1 represents a potential therapeutic target for age-related cardiac decline.

Related Concept Videos

Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
659
The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
3.4K
Changes in the Appendicular Skeleton with Age01:09

Changes in the Appendicular Skeleton with Age

The upper and lower limb initially develops as a small bulge called a limb bud, which appears on the lateral side of the early embryo. The upper limb bud appears near the end of the fourth week of development, with the lower limb bud appearing shortly after.
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...
3.4K
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
193
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
266
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
239